Cidara Therapeutics Inc
NASDAQ:CDTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cidara Therapeutics Inc
NASDAQ:CDTX
|
US |
|
C
|
Christian Dior SE
XMUN:DIO
|
FR |
|
C
|
CrowdStrike Holdings Inc
F:45C
|
US |
|
M
|
Melco Resorts & Entertainment Ltd
F:MAS
|
HK |
|
Costa Group Holdings Ltd
ASX:CGC
|
AU |
|
Atos SE
PAR:ATO
|
FR |
|
Banco Bradesco SA
NYSE:BBD
|
BR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
KR |
|
Khiron Life Sciences Corp
F:4KH
|
CA |
|
Credit Saison Co Ltd
TSE:8253
|
JP |
|
J&T Global Express Ltd
F:J92
|
CN |
|
Guangdong Songfa Ceramics Co Ltd
SSE:603268
|
CN |
Wall St Price Targets
CDTX Price Targets Summary
Cidara Therapeutics Inc
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CDTX's stock price target?
Not Available
CDTX does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Cidara Therapeutics Inc?
Projected CAGR
318%
The compound annual growth rate for Revenue over the next 4 years is 318%.